Apoptosis in Buruli ulcer: A clinicopathological study of 45 cases

Histopathology

Volumn 61, Issue 2, 2012, Pages 224-236

  Zavattaro, Elisa ^a   Boccafoschi, Francesca ^a   Borgogna, Cinzia ^a   Conca, Alessandro ^a   Johnson, Roch Christian ^b   Sopoh, Ghislain Emmanuel ^c   Dossou, Ange Dodji ^c   Colombo, Enrico ^a   Clemente, Claudio ^d   Leigheb, Giorgio ^a   Valente, Guido ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Fondation Raoul Follereau ^*  (Benin)

^c Centre de Dépistage et de Traitement de l Ulcère de Buruli CDTUB   (Benin)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Apoptosis; Bax; Buruli ulcer; Caspase; TUNEL

Indexed keywords

CASPASE 3; CASPASE 8; PROTEIN BAX; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC THERAPY; APOPTOSIS; ARTICLE; BURULI ULCER; CELL INFILTRATION; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLAMMATION; LYMPHOCYTE COUNT; MALE; NERVE FIBER; NERVE INJURY; NEUTROPHIL COUNT; NICK END LABELING; PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLEROSIS; SKIN BIOPSY; SKIN EDEMA; SKIN GRANULOMA; TISSUE NECROSIS;

ANTI-BACTERIAL AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BURULI ULCER; CASPASE 3; CASPASE 8; FEMALE; HUMANS; INFLAMMATION; MALE; NERVE DEGENERATION;

MYCOBACTERIUM ULCERANS;

EID: 84864382864     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04206.x     Document Type: Article

References (31)

1. van der Werf TS, Stinear T, Stienstra Y et al. Mycolactones and Mycobacterium ulcerans disease. Lancet 2003; 362; 1062-1064.
2. Wansbrough-Jones M, Phillips R. Buruli ulcer: emerging from obscurity. Lancet 2006; 367; 1849-1858.
3. Guarner J, Bartlett J, Whitney EA et al. Histopathologic features of Mycobacterium ulcerans infection. Emerg. Infect. Dis. 2003; 9; 651-656.
4. Goto M, Nakanaga K, Aung T et al. Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in Buruli ulcer. Am. J. Pathol. 2006; 168; 805-811.
5. Pahlevan AA, Wright DJ, Andrews C et al. The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function. J. Immunol. 1999; 163; 3928-3935.
6. Prevot G, Bourreau E, Pascalis H et al. Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease. Infect. Immun. 2004; 72; 958-965.
7. Kiszewski AE, Becerril E, Aguilar LD et al. The local immune response in ulcerative lesions of Buruli disease. Clin. Exp. Immunol. 2006; 143; 445-451.
8. Zavattaro E, Mesturini R, Dossou A et al. Serum cytokine profile during Mycobacterium ulcerans infection (Buruli ulcer). Int. J. Dermatol. 2010; 49; 1297-1302.
9. Phillips R, Horsfield C, Kuijper S et al. Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosis. Clin. Vaccine Immunol. 2006; 13; 253-257.
10. Schipper HS, Rutgers B, Huitema MG et al. Systemic and local interferon-gamma production following Mycobacterium ulcerans infection. Clin. Exp. Immunol. 2007; 150; 451-459.
11. Walsh DS, Meyers WM, Portaels F et al. High rates of apoptosis in human Mycobacterium ulcerans culture-positive Buruli ulcer skin lesions. Am. J. Trop. Med. Hyg. 2005; 73; 410-415.
12. Bozzo C, Tiberio R, Graziola F et al. A Mycobacterium ulcerans toxin, mycolactone, induces apoptosis in primary human keratinocytes and in HaCaT cells. Microbes Infect. 2010; 12; 1258-1263.
13. Tang D, Kidd VJ. Cleavage of DFF-45/ICAD by multiple caspases is essential for its function during apoptosis. J. Biol. Chem. 1998; 273; 28549-2852.
14. Krajewski S, Krajewska M, Ellerby LM et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl Acad. Sci. USA 1999; 96; 5752-5777.
15. Adams JM, Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr. Opin. Immunol. 2007; 19; 488-496.
16. World Health Organization (WHO). Global Buruli Ulcer Initiative: provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). Available at:
17. van der Werf TS, van der Graaf WT, Tappero JW et al. Mycobacterium ulcerans infection. Lancet 1999; 354; 1013-1018.
18. Schutte D, Um-Boock A, Mensah-Quainoo E et al. Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin. PLoS Negl. Trop. Dis. 2007; 1; e2.
19. Etuaful S, Carbonnelle B, Grosset J et al. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob. Agents Chemother. 2005; 49; 3182-3186.
20. Mukherjee A, Misra RS. Comparative histology of skin and nerve granulomas in leprosy patients. Lepr. Rev. 1988; 59; 177-180.
21. Narayanan RB. Immunopathology of leprosy granulomas-current status: a review. Lepr. Rev. 1988; 59; 75-82.
22. En J, Goto M, Nakanaga K et al. Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (Buruli ulcer) in a murine study. Infect. Immun. 2008; 76; 2002-2007.
23. Teles RM, Antunes SL, Jardim MR et al. Expression of metalloproteinases (MMP-2, MMP-9, and TACE) and TNF-alpha in the nerves of leprosy patients. J. Peripher. Nerv. Syst. 2007; 12; 195-204.
24. Galluzzi L, Maiuri MC, Vitale I et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ. 2007; 14; 1237-1243.
25. Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J. Clin. Invest. 2005; 115; 2625-2632.
26. Yousefi S, Perozzo R, Schmid I et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell Biol. 2006; 8; 1124-1132.
27. Sato A, Satake A, Hiramoto A et al. Molecular mechanisms in two cell death-types, necrosis and apoptosis, induced by 5-fluoro-2′-deoxyuridine. Nucleic Acids Symp. Ser (Oxf.) 2008; 52; 627-628.
28. Ravikumar B, Rubinsztein DC. Role of autophagy in the clearance of mutant huntingtin: a step towards therapy? Mol. Aspects Med. 2006; 27; 520-527.
29. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002; 296; 1634-1635.
30. Slee EA, Adrain C, Martin SJ. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 2001; 276; 7320-7326.
31. Nomura M, Shimizu S, Ito T et al. Apoptotic cytosol facilitates Bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2. Cancer Res. 1999; 59; 5542-5548.